Artificial Intelligence Can Detect Glucose Levels via ECG
|
By HospiMedica International staff writers Posted on 20 Jan 2020 |

Image: ECG heartbeat segments help identify hypoglycemia events (Photo courtesy of University of Warwick)
A new study shows how artificial intelligence (AI) can be used to detect hypoglycemic events from raw electrocardiogram (ECG) signals.
Developed at the University of Warwick (Coventry, United Kingdom), the University of Napoli Federico II (Naples, Italy), Western University (WU; London, Canada), and other institutions, the personalized medicine approach uses AI to automatically detect nocturnal hypoglycemia with just a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices. A visualization method then enables the clinicians to establish which part of the ECG signal is significantly associated with a hypoglycemic event in each individual subject.
The AI model is trained with each subject's own dataset, which is comprised of both ECG and glucose recordings as measured by two sensors worn for a period of 8-14 days. The researchers conducted two pilot studies involving eight healthy volunteers, which found that the average sensitivity and specificity of the AI approach for hypoglycemia detection was about 82%, comparable to current continuous glucose monitoring (CGM) device performance. The study was published on January 13, 2020, in Nature Scientific Reports.
“Fingerpicks are never pleasant, and in some circumstances particularly cumbersome. Our innovation consisted of using AI for automatically detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping,” said senior author Leandro Pecchia, PhD, of the University of Warwick School of Engineering. “Our approach enables personalized tuning of detection algorithms and emphasizes how hypoglycemic events affect ECG. Based on this information, clinicians can adapt the therapy to each individual.”
Hypoglycemia can cause pronounced physiological responses as a consequence of autonomic activation, principally of the sympatho-adrenal system, which results in the release of epinephrine (adrenaline). The autonomic stimulus provokes hemodynamic changes in order maintain a supply of glucose to the brain and promote the hepatic production of glucose. Hemodynamic changes associated with hypoglycemia include an increase in heart rate and peripheral systolic blood pressure, a fall in central blood pressure, reduced peripheral arterial resistance, and an increase in myocardial contractility, stroke volume, and cardiac output.
Related Links:
University of Warwick
University of Napoli Federico II
Western University
Developed at the University of Warwick (Coventry, United Kingdom), the University of Napoli Federico II (Naples, Italy), Western University (WU; London, Canada), and other institutions, the personalized medicine approach uses AI to automatically detect nocturnal hypoglycemia with just a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices. A visualization method then enables the clinicians to establish which part of the ECG signal is significantly associated with a hypoglycemic event in each individual subject.
The AI model is trained with each subject's own dataset, which is comprised of both ECG and glucose recordings as measured by two sensors worn for a period of 8-14 days. The researchers conducted two pilot studies involving eight healthy volunteers, which found that the average sensitivity and specificity of the AI approach for hypoglycemia detection was about 82%, comparable to current continuous glucose monitoring (CGM) device performance. The study was published on January 13, 2020, in Nature Scientific Reports.
“Fingerpicks are never pleasant, and in some circumstances particularly cumbersome. Our innovation consisted of using AI for automatically detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping,” said senior author Leandro Pecchia, PhD, of the University of Warwick School of Engineering. “Our approach enables personalized tuning of detection algorithms and emphasizes how hypoglycemic events affect ECG. Based on this information, clinicians can adapt the therapy to each individual.”
Hypoglycemia can cause pronounced physiological responses as a consequence of autonomic activation, principally of the sympatho-adrenal system, which results in the release of epinephrine (adrenaline). The autonomic stimulus provokes hemodynamic changes in order maintain a supply of glucose to the brain and promote the hepatic production of glucose. Hemodynamic changes associated with hypoglycemia include an increase in heart rate and peripheral systolic blood pressure, a fall in central blood pressure, reduced peripheral arterial resistance, and an increase in myocardial contractility, stroke volume, and cardiac output.
Related Links:
University of Warwick
University of Napoli Federico II
Western University
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







